Company: BWNB
Filing Date: 2025-06-10
Form Type: 424B5
Source: 0001104659-25-058204
Chunk: 14

Company: Babcock & Wilcox Enterprises, Inc.
Filing Date: 2025-06-10
Form: 424B5
Chunk 14
---
 amount of any dividends in light of applicable law, contractual restrictions
limiting our ability to pay dividends, our earnings and cash flows, our capital requirements, our financial condition, and other factors
our board of directors deems relevant. Accordingly, our shareholders may have to sell some or all of their shares of our Common Stock
in order to generate cash flow from their investment.

We are subject to continuing compliance monitoring by the NYSE. If we fail to maintain compliance with the NYSE’s minimum share price requirement we may be at risk of the NYSE delisting our Common Stock, which would have an adverse impact on the trading volume, liquidity and market price of our Common Stock.

Our Common Stock is currently
listed for trading on the NYSE, and the continued listing of our Common Stock on the NYSE is subject to our compliance with the listing
standards. We are currently in compliance with the continued listing standards of the NYSE; however, if we are unable to maintain compliance
with the NYSE criteria for continued listing, our Common Stock may be subject to delisting. Delisting may have an adverse effect on the
liquidity of our Common Stock and, as a result, the market price for our Common Stock might decline. A delisting of our Common Stock from
the NYSE could negatively impact us as it would likely reduce the liquidity and market price of our Common Stock; reduce the number of
investors willing to hold or acquire our Common Stock; and negatively impact our ability to access equity markets and obtain financing.

Provisions in our corporate documents and Delaware law could delay or prevent a change in control of the Company, even if that change may be considered beneficial by some shareholders.

The existence of some provisions
of our certificate of incorporation and bylaws and Delaware law could discourage, delay or prevent a change in control of the Company
that a shareholder may consider favorable.

In addition, we are subject
to Section 203 of the Delaware General Corporation Law, which may have an anti-takeover effect with respect to transactions not approved
in advance by our board of directors, including discouraging takeover attempts that might result in a premium over the market price for
shares of our Common Stock.

We believe these provisions
protect our shareholders from coercive or otherwise unfair takeover tactics by requiring potential acquirors to negotiate with our board
of directors and by providing our board of directors with more time to assess any acquisition proposal and are not intended to make the
Company immune from takeovers. However, these provisions apply